Alentis Therapeutics
Alentis Therapeutics raised US$181.4M in Series D funding.
Email and contact information
Company website: alentis.ch
Decision maker info and email: SIGNUP TO UNBLOCK
Headquarters: , (Switzerland)
Industry: Biotechnology
Business model:
Funding
- Total funding amount: $181,400,000 (in USD)
- Estimated valuation: $907,000,000.00
- Latest deal type: Series D
- First fundind year: 2024
Growth
Founders:
Top investors:
Team size: SIGNUP TO UNBLOCK
Revenue: SIGNUP TO UNBLOCK